<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Drug Topics articles</title><description>Drug Topics articles</description><link>https://www.drugtopics.com/news</link><category>Drug Topics articles</category><copyright>© 2026 MJH Life Sciences™ and Drug Topics. All rights reserved.</copyright><lastBuildDate>Fri, 09 Oct 2026 22:12:46 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.drugtopics.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Drug Topics articles</title><width>144</width><height>47</height><link>https://www.drugtopics.com/news</link><url>https://www.drugtopics.com/logo.webp</url></image><item><title>&lt;![CDATA[Pharmacist Pain Management Clinics: The Expert as the Pain Coach]]&gt;</title><link>https://www.drugtopics.com/view/pharmacist-pain-management-clinics-the-expert-as-the-pain-coach</link><guid isPermaLink="true">https://www.drugtopics.com/view/pharmacist-pain-management-clinics-the-expert-as-the-pain-coach</guid><description>&lt;![CDATA[Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.]]&gt;</description><pubDate>Fri, 09 Oct 2026 20:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Serotype 34 Causes Pneumococcal Meningitis in Child With Cochlear Implants]]&gt;</title><link>https://www.drugtopics.com/view/serotype-34-causes-pneumococcal-meningitis-in-child-with-cochlear-implants</link><guid isPermaLink="true">https://www.drugtopics.com/view/serotype-34-causes-pneumococcal-meningitis-in-child-with-cochlear-implants</guid><description>&lt;![CDATA[A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.]]&gt;</description><pubDate>Fri, 09 Oct 2026 18:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Retatrutide Delivers 20.8% Weight Loss in Adults With Type 2 Diabetes]]&gt;</title><link>https://www.drugtopics.com/view/retatrutide-delivers-20-8-weight-loss-in-adults-with-type-2-diabetes</link><guid isPermaLink="true">https://www.drugtopics.com/view/retatrutide-delivers-20-8-weight-loss-in-adults-with-type-2-diabetes</guid><description>&lt;![CDATA[Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.]]&gt;</description><pubDate>Fri, 09 Oct 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Independent Pharmacies Remain Resilient, Essential Community Providers | NCPA 2026]]&gt;</title><link>https://www.drugtopics.com/view/independent-pharmacies-remain-resilient-essential-community-providers-ncpa-2026</link><guid isPermaLink="true">https://www.drugtopics.com/view/independent-pharmacies-remain-resilient-essential-community-providers-ncpa-2026</guid><description>&lt;![CDATA[In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.]]&gt;</description><pubDate>Fri, 09 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Community Pharmacy Partnerships That Close the Gaps]]&gt;</title><link>https://www.drugtopics.com/view/community-pharmacy-partnerships-that-close-the-gaps</link><guid isPermaLink="true">https://www.drugtopics.com/view/community-pharmacy-partnerships-that-close-the-gaps</guid><description>&lt;![CDATA[Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.]]&gt;</description><pubDate>Thu, 08 Oct 2026 20:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Integrated Care and the Keys to Successful GLP-1 Therapy]]&gt;</title><link>https://www.drugtopics.com/view/integrated-care-and-the-keys-to-successful-glp-1-therapy</link><guid isPermaLink="true">https://www.drugtopics.com/view/integrated-care-and-the-keys-to-successful-glp-1-therapy</guid><description>&lt;![CDATA[In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.]]&gt;</description><pubDate>Thu, 08 Oct 2026 18:30:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Pharmacist Protocol Is Linked With More Same-Day Vaccine Coadministration]]&gt;</title><link>https://www.drugtopics.com/view/pharmacist-protocol-is-linked-with-more-same-day-vaccine-coadministration</link><guid isPermaLink="true">https://www.drugtopics.com/view/pharmacist-protocol-is-linked-with-more-same-day-vaccine-coadministration</guid><description>&lt;![CDATA[A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.]]&gt;</description><pubDate>Thu, 08 Oct 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[FAQ: Policies for Pharmacists to Track Heading into 2026 Midterms]]&gt;</title><link>https://www.drugtopics.com/view/policies-for-pharmacists-to-track-heading-into-2026-midterms</link><guid isPermaLink="true">https://www.drugtopics.com/view/policies-for-pharmacists-to-track-heading-into-2026-midterms</guid><description>&lt;![CDATA[In part 2 of our pre-election series, detailing key health policies for pharmacists at this year’s midterms, a legal expert touches on MFN pricing, ACA subsidies, and more. ]]&gt;</description><pubDate>Thu, 08 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Addressing Medication Adherence in Cardiometabolic Health]]&gt;</title><link>https://www.drugtopics.com/view/addressing-medication-adherence-in-cardiometabolic-health</link><guid isPermaLink="true">https://www.drugtopics.com/view/addressing-medication-adherence-in-cardiometabolic-health</guid><description>&lt;![CDATA[Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.]]&gt;</description><pubDate>Wed, 07 Oct 2026 20:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Wicked Good Cardiometabolic Chat: Incretin Therapies in Pediatric Obesity, T2D]]&gt;</title><link>https://www.drugtopics.com/view/wicked-good-cardiometabolic-chat-incretin-therapies-in-pediatric-obesity-t2d</link><guid isPermaLink="true">https://www.drugtopics.com/view/wicked-good-cardiometabolic-chat-incretin-therapies-in-pediatric-obesity-t2d</guid><description>&lt;![CDATA[In this episode, our hosts examine the expanding role of incretin therapies in children and adolescents with obesity and type 2 diabetes.]]&gt;</description><pubDate>Wed, 07 Oct 2026 18:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Q&amp;A: What It Will Take to Keep Patients on GLP-1s Long-Term]]&gt;</title><link>https://www.drugtopics.com/view/what-it-will-take-to-keep-patients-on-glp-1s-long-term</link><guid isPermaLink="true">https://www.drugtopics.com/view/what-it-will-take-to-keep-patients-on-glp-1s-long-term</guid><description>&lt;![CDATA[GLP-1 adherence requires integrated care teams, administrative technology, and proactive clinical support to tackle complex challenges.]]&gt;</description><pubDate>Wed, 07 Oct 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[How Pharmacists Can Join the Menopause Care Team]]&gt;</title><link>https://www.drugtopics.com/view/how-pharmacists-can-join-the-menopause-care-team</link><guid isPermaLink="true">https://www.drugtopics.com/view/how-pharmacists-can-join-the-menopause-care-team</guid><description>&lt;![CDATA[Pharmacist Stephanie Young Moss explains menopause symptoms, hormone therapy guidance, and how pharmacists can expand menopause care access.]]&gt;</description><pubDate>Wed, 07 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[HIV Testing Before and During PrEP: Getting It Right]]&gt;</title><link>https://www.drugtopics.com/view/hiv-testing-before-and-during-prep-getting-it-right</link><guid isPermaLink="true">https://www.drugtopics.com/view/hiv-testing-before-and-during-prep-getting-it-right</guid><description>&lt;![CDATA[Confirming HIV-negative status before starting PrEP, and at every follow-up, protects against partial treatment and drug resistance. The faculty compare testing strategies across clinical and pharmacy settings.]]&gt;</description><pubDate>Wed, 07 Oct 2026 12:05:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Starting the HIV PrEP Conversation in Primary Care and Pharmacy]]&gt;</title><link>https://www.drugtopics.com/view/starting-the-hiv-prep-conversation-in-primary-care-and-pharmacy</link><guid isPermaLink="true">https://www.drugtopics.com/view/starting-the-hiv-prep-conversation-in-primary-care-and-pharmacy</guid><description>&lt;![CDATA[Patients rarely ask about PrEP unless someone asks first. The faculty describe how primary care clinicians and community pharmacists can open the conversation with confidence and without judgment.]]&gt;</description><pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Cost-Plus Pricing Reshapes Pharmacy, But Savings Are Not Guaranteed]]&gt;</title><link>https://www.drugtopics.com/view/cost-plus-pricing-reshapes-pharmacy-but-savings-are-not-guaranteed</link><guid isPermaLink="true">https://www.drugtopics.com/view/cost-plus-pricing-reshapes-pharmacy-but-savings-are-not-guaranteed</guid><description>&lt;![CDATA[Research shows that cost-plus pricing can lower drug costs dramatically, depending on where in the supply chain the markup is applied.]]&gt;</description><pubDate>Tue, 06 Oct 2026 20:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Diabetes Medication Adherence Lags for Black and Hispanic Medicare Patients]]&gt;</title><link>https://www.drugtopics.com/view/diabetes-medication-adherence-lags-for-black-and-hispanic-medicare-patients</link><guid isPermaLink="true">https://www.drugtopics.com/view/diabetes-medication-adherence-lags-for-black-and-hispanic-medicare-patients</guid><description>&lt;![CDATA[Medicaid and Part D low-income subsidy enrollment narrowed some gaps, but much of the disparity occurred within the same plans.]]&gt;</description><pubDate>Tue, 06 Oct 2026 18:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[FAQ: How the 2026 Midterms Could Reshape Pharmacy Policy]]&gt;</title><link>https://www.drugtopics.com/view/how-the-2026-midterms-could-reshape-pharmacy-policy</link><guid isPermaLink="true">https://www.drugtopics.com/view/how-the-2026-midterms-could-reshape-pharmacy-policy</guid><description>&lt;![CDATA[In part 1 of our midterm election FAQ series, AJ Barbarito, Esq, breaks down ongoing legal developments for pharmacists and what a change in Congressional control could mean for the profession.]]&gt;</description><pubDate>Tue, 06 Oct 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Model Finds NHS England–Style Diabetes Prevention Program Cost-Effective]]&gt;</title><link>https://www.drugtopics.com/view/model-finds-nhs-england-style-diabetes-prevention-program-cost-effective</link><guid isPermaLink="true">https://www.drugtopics.com/view/model-finds-nhs-england-style-diabetes-prevention-program-cost-effective</guid><description>&lt;![CDATA[A modeling study projects that a structured lifestyle program for adults with prediabetes would be cost-effective and likely cost saving.]]&gt;</description><pubDate>Tue, 06 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[The Pharmacist&apos;s Expanding Role in COVID-19 Vaccine Confidence]]&gt;</title><link>https://www.drugtopics.com/view/the-pharmacist-s-expanding-role-in-covid-19-vaccine-confidence</link><guid isPermaLink="true">https://www.drugtopics.com/view/the-pharmacist-s-expanding-role-in-covid-19-vaccine-confidence</guid><description>&lt;![CDATA[Trusted, accessible, and positioned across a patient&apos;s broader health needs, pharmacists remain the frontline for COVID-19 vaccine confidence as the platform landscape keeps evolving.]]&gt;</description><pubDate>Tue, 06 Oct 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Pricing Formulas Multiply, Pharmacists Translate Complexity Into Care]]&gt;</title><link>https://www.drugtopics.com/view/pricing-formulas-multiply-pharmacists-translate-complexity-into-care</link><guid isPermaLink="true">https://www.drugtopics.com/view/pricing-formulas-multiply-pharmacists-translate-complexity-into-care</guid><description>&lt;![CDATA[As a government price-setting formula, the same arithmetic has produced the opposite result.]]&gt;</description><pubDate>Mon, 05 Oct 2026 20:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Orforglipron Shows Greater A1C, Weight Reduction Than Oral Semaglutide]]&gt;</title><link>https://www.drugtopics.com/view/orforglipron-shows-greater-a1c-weight-reduction-than-oral-semaglutide</link><guid isPermaLink="true">https://www.drugtopics.com/view/orforglipron-shows-greater-a1c-weight-reduction-than-oral-semaglutide</guid><description>&lt;![CDATA[Orforglipron lowered A1C and body weight more than oral semaglutide 25 mg at 52 weeks, but the estimate comes from an indirect comparison.]]&gt;</description><pubDate>Mon, 05 Oct 2026 18:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[How DTC GLP-1s Improve Access But Hurt Adherence]]&gt;</title><link>https://www.drugtopics.com/view/how-dtc-glp-1s-improve-access-but-hurt-adherence</link><guid isPermaLink="true">https://www.drugtopics.com/view/how-dtc-glp-1s-improve-access-but-hurt-adherence</guid><description>&lt;![CDATA[Brian Smith, PharmD, explains how direct-to-consumer GLP-1 pathways broaden initial access but endanger long-term patient adherence.]]&gt;</description><pubDate>Mon, 05 Oct 2026 14:30:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[American Pharmacists Month: Burnout and PBMs Remain Barriers for Community Pharmacists]]&gt;</title><link>https://www.drugtopics.com/view/burnout-and-pbms-remain-barriers-for-community-pharmacists</link><guid isPermaLink="true">https://www.drugtopics.com/view/burnout-and-pbms-remain-barriers-for-community-pharmacists</guid><description>&lt;![CDATA[Pharmacists face burnout and financial strain as PBMs take big cuts, prompting urgent calls for reform to protect patient care and community pharmacies.]]&gt;</description><pubDate>Mon, 05 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Technicians Aren&apos;t Asking for a Party]]&gt;</title><link>https://www.drugtopics.com/view/technicians-aren-t-asking-for-a-party</link><guid isPermaLink="true">https://www.drugtopics.com/view/technicians-aren-t-asking-for-a-party</guid><description>&lt;![CDATA[What pharmacy technicians say would actually make them feel seen on World Pharmacy Technician Day, and the other 364 days of the year.]]&gt;</description><pubDate>Sun, 04 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Indirect Comparison Links Tirzepatide to Greater Weight Loss Than Semaglutide]]&gt;</title><link>https://www.drugtopics.com/view/indirect-comparison-links-tirzepatide-to-greater-weight-loss-than-semaglutide</link><guid isPermaLink="true">https://www.drugtopics.com/view/indirect-comparison-links-tirzepatide-to-greater-weight-loss-than-semaglutide</guid><description>&lt;![CDATA[The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.]]&gt;</description><pubDate>Sat, 03 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Infections Fall With Azithromycin for Unscheduled Cesarean Deliveries]]&gt;</title><link>https://www.drugtopics.com/view/infections-fall-with-azithromycin-for-unscheduled-cesarean-deliveries</link><guid isPermaLink="true">https://www.drugtopics.com/view/infections-fall-with-azithromycin-for-unscheduled-cesarean-deliveries</guid><description>&lt;![CDATA[A 1.6-million-birth analysis finds that adoption of a 2016 trial&apos;s antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.]]&gt;</description><pubDate>Fri, 02 Oct 2026 18:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Data Links GLP-1 With Fewer Asthma Attacks, Lower Psychiatric Risk]]&gt;</title><link>https://www.drugtopics.com/view/data-links-glp-1-with-fewer-asthma-attacks-lower-psychiatric-risk</link><guid isPermaLink="true">https://www.drugtopics.com/view/data-links-glp-1-with-fewer-asthma-attacks-lower-psychiatric-risk</guid><description>&lt;![CDATA[New findings suggest semaglutide&apos;s benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.]]&gt;</description><pubDate>Fri, 02 Oct 2026 14:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[FDA Expands Mavacamten for Children with oHCM]]&gt;</title><link>https://www.drugtopics.com/view/fda-expands-mavacamten-for-children-with-ohcm</link><guid isPermaLink="true">https://www.drugtopics.com/view/fda-expands-mavacamten-for-children-with-ohcm</guid><description>&lt;![CDATA[First approved for adults in 2022, the therapy is now cleared for adults and pediatric patients weighing 66 lbs or more with symptomatic obstructive hypertrophic cardiomyopathy.]]&gt;</description><pubDate>Fri, 02 Oct 2026 13:30:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Why Rural Pharmacies Are Essential Infrastructure in US Health Care]]&gt;</title><link>https://www.drugtopics.com/view/why-rural-pharmacies-are-essential-infrastructure-in-us-health-care</link><guid isPermaLink="true">https://www.drugtopics.com/view/why-rural-pharmacies-are-essential-infrastructure-in-us-health-care</guid><description>&lt;![CDATA[With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.]]&gt;</description><pubDate>Thu, 01 Oct 2026 18:30:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item><item><title>&lt;![CDATA[Nearly 1 in 6 Pediatric Patients Have Nutritional Deficiency With GLP-1s]]&gt;</title><link>https://www.drugtopics.com/view/nearly-1-in-6-pediatric-patients-have-nutritional-deficiency-with-glp-1s</link><guid isPermaLink="true">https://www.drugtopics.com/view/nearly-1-in-6-pediatric-patients-have-nutritional-deficiency-with-glp-1s</guid><description>&lt;![CDATA[A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.]]&gt;</description><pubDate>Thu, 01 Oct 2026 18:00:00 GMT</pubDate><media:credit role="publishing company">Drug Topics</media:credit><category>us</category><source url="https://www.drugtopics.com/rss.xml">Drug Topics Articles</source></item></channel></rss>